Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesPhase II trials of erlotinib or gefitinib in patients with recurrent meningioma
Journal of Neuro-Oncology, 07/02/09
Wen PY et al. - Although treatment was well-tolerated, neither gefitinib nor erlotinib appear to have significant activity against recurrent meningioma. The role of EGFR inhibitors in meningiomas is unclear. Evaluation of multi-targeted inhibitors and EGFR inhibitors in combination with other targeted molecular agents may be warranted.
Related Articles
A meningioma of the scalp that might have developed from a rudimentary meningocele
Clinical and Experimental Dermatology, 10/16/09
Relevance Score: 90%
Jugular fossa meningioma: Presentation and treatment options
ENT Journal, 10/21/09
Relevance Score: 89%
Diagnosis and Treatment of the Primary Malignant Meningioma in Mediastinum: A Case Report
Southern Medical Journal, 11/10/09
Relevance Score: 88%
Radiation-induced meningiomas: A shadow in the success story of childhood leukemia
Neuro-Oncology, 10/06/09
Relevance Score: 88%
Does protein expression predict recurrence of benign World Health Organization grade I meningioma
Human Pathology, 10/08/09
Relevance Score: 87%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiformeTEST
Journal of Neuro-Oncology, 12/17/09
Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients
International Journal of Cancer, 12/16/09
Brain metastases in HER2-positive breast cancer: The evolving role of lapatinib
Critical Reviews in Oncology/Hematology, 12/15/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Port central venous catheters–associated bloodstream infection during outpatient-based chemotherapyTEST
Medical Oncology, 12/17/09
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiformeTEST
Journal of Neuro-Oncology, 12/17/09
CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease
Breast Cancer Research, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor